Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Jun 08, 2026
BWX Technologies (BWXT) Reports Strong Q1 2026 Results with +26% Revenue Growth

BWX Technologies (BWXT) Reports Strong Q1 2026 Results with +26% Revenue Growth

Key Takeaways

  • BWX Technologies delivered strong first-quarter 2026 results, with revenue rising 26% year-over-year and earnings beating consensus estimates.
  • The company raised its full-year 2026 financial guidance following robust backlog execution and operational improvements.
  • A $1.4 billion contract win for the Naval Nuclear Propulsion Program added significant momentum in the defense segment.
  • Strategic acquisition of Precision Components Group bolsters U.S. commercial nuclear manufacturing capabilities.
  • Analyst sentiment remains positive, with multiple rating upgrades and increased price targets in recent weeks.

Market Context for BWXT

In recent weeks, BWX Technologies has operated in a favorable environment driven by sustained demand in nuclear defense and commercial energy sectors. The stock has reflected steady investor interest amid broader industry tailwinds from government contracts and nuclear infrastructure needs. Trading activity has aligned with positive sentiment surrounding earnings momentum and strategic positioning, maintaining relevance within the industrials and aerospace and defense space. Overall market conditions continue to support companies with strong backlogs and exposure to national security priorities.

Recent Developments Driving BWXT Price Action

On May 4, 2026, BWX Technologies reported first-quarter 2026 financial results that exceeded analyst expectations and prompted an upward revision to full-year guidance. Revenue reached $860.2 million, representing a 26% increase from the prior-year quarter, while non-GAAP earnings per share climbed to $1.12, surpassing consensus estimates by approximately 20 cents. The Government Operations segment contributed $577.9 million in revenue, supported by naval nuclear work, while Commercial Operations surged 121% to $283.6 million, fueled by demand for nuclear components, fuel, and medical isotopes. Management attributed the performance to higher throughput, improved operating efficiency, and strong backlog execution. The company also raised 2026 guidance to revenue above $3.75 billion, adjusted EBITDA between $650 million and $665 million, non-GAAP EPS of $4.60 to $4.75, and free cash flow of $315 million to $330 million. These results contributed to positive price movement as investors responded to the beat and optimistic outlook.

Further momentum came from a May 12 announcement of $1.4 billion in new contracts for the Naval Nuclear Propulsion Program. This award reinforced BWXT’s role as a key supplier of nuclear components for U.S. Navy submarines and aircraft carriers, enhancing visibility into future revenue streams and supporting sentiment in the defense-oriented portion of the business.

On June 4, 2026, the company highlighted progress in its TRISO fuel manufacturing efforts, enabling the first new reactor criticality under a Department of Energy program. This development underscored BWXT’s expanding footprint in advanced nuclear technologies. Additionally, the earlier acquisition of Precision Components Group, LLC, announced alongside earnings, establishes dedicated U.S. capacity for commercial nuclear component production, addressing domestic supply chain priorities.

Analyst actions reinforced the positive narrative. Deutsche Bank upgraded the stock to Buy and raised its price target, while other firms including BTIG and Argus reiterated Buy ratings with elevated targets. Consensus among analysts remains Buy, with average 12-month price targets reflecting meaningful upside potential. These developments collectively supported constructive price action by linking operational successes to tangible growth catalysts. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

2026 Outlook and Key Factors to Monitor

Looking ahead to 2026, BWX Technologies is positioned to benefit from sustained U.S. government spending on naval nuclear propulsion and broader nuclear energy initiatives. The company’s substantial backlog provides a foundation for revenue visibility, while strategic investments in commercial nuclear manufacturing and advanced fuel technologies such as TRISO and high-assay low-enriched uranium (HALEU) align with evolving national priorities around energy security and decarbonization. Investors may monitor execution on raised guidance, progress on the Precision Components Group integration, and additional contract awards in the defense sector. Macroeconomic factors including interest rates, federal budget outcomes, and supply chain stability could influence operations. Regulatory developments related to nuclear licensing and export controls remain relevant considerations. Competitive positioning in both government and commercial markets, along with free cash flow generation, will be important metrics for assessing long-term financial health. From what I see, one area worth watching is how execution on these catalysts plays out in the coming quarters.

Exploring Automated Trading Approaches

Tickeron’s Trending AI Robots page highlights a curated selection of high-performing AI trading bots from a much larger library of hundreds available across thousands of tickers. Only those demonstrating the strongest suitability for prevailing market conditions earn placement in this section. Bots feature varied trading styles, strategies, timeframes, performance metrics, and ticker coverage, with many showing win rates in the 60-80% range and profit factors above 1.5 in recent evaluations. This diversity allows investors to explore automated approaches tailored to specific risk profiles and market environments. I find this section helpful when evaluating how different strategies might align with names like BWXT under current conditions. Explore the full selection on the Trending AI Robots page for more details.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BWXT

BWXT's Indicator enters downward trend

The Aroon Indicator for BWXT entered a downward trend on August 07, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 122 similar instances where the Aroon Indicator formed such a pattern. In of the 122 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BWXT as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BWXT turned negative on August 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BWXT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where BWXT's RSI Indicator exited the oversold zone, of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BWXT advanced for three days, in of 330 cases, the price rose further within the following month. The odds of a continued upward trend are .

BWXT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BWXT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (10.764) is normal, around the industry mean (7.037). P/E Ratio (40.617) is within average values for comparable stocks, (60.208). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.077). Dividend Yield (0.007) settles around the average of (0.017) among similar stocks. P/S Ratio (4.102) is also within normal values, averaging (20.174).

Notable companies

The most notable companies in this group are GE Aerospace (NYSE:GE), Boeing Company (NYSE:BA), Lockheed Martin Corp (NYSE:LMT), Northrop Grumman Corp (NYSE:NOC), Virgin Galactic Holdings (NYSE:SPCE).

Industry description

Aerospace & Defense is one of largest industries in the U.S., mainly comprising the following areas: commercial airliners, military aircraft, missiles, space, and general aviation. Focused heavily on research & development, it is also one of the fastest growing industries. Military aircraft has the largest market share in the industry’s sales, followed by space systems, civil aircraft, and missiles. Aerospace exports, directly and indirectly, support more jobs than the export of any other commodity, according to a study by the U.S. Department of Commerce. Boeing Company, Lockheed Martin Corporation and General Electric Company are some of the most prominent players in this space.

Market Cap

The average market capitalization across the Aerospace & Defense Industry is 40.4B. The market cap for tickers in the group ranges from 4.49 to 1.81T. SPCX holds the highest valuation in this group at 1.81T. The lowest valued company is BDRPF at 4.49.

High and low price notable news

The average weekly price growth across all stocks in the Aerospace & Defense Industry was -8%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was -3%. NPK experienced the highest price growth at 7%, while DFSC experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Aerospace & Defense Industry was -31%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was -7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 68
Price Growth Rating: 55
SMR Rating: 78
Profit Risk Rating: 73
Seasonality Score: -30 (-100 ... +100)
View a ticker or compare two or three
BWXT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of components and services to nuclear power industry

Industry AerospaceDefense

Profile
Details
Industry
Aerospace And Defense
Address
800 Main Street
Phone
+1 980 365-4300
Employees
7800
Web
https://www.bwxt.com
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.